Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
XtalPi Inc. logo — Dedicated to building a technology platform using AI and rob...

XtalPi Inc.

Dedicated to building a technology platform using AI and robotics to drive innovation in multiple industries.

Founded 2014 United States Somerville, United States 398 employees IPO Total: $1.76B Biotechnology, Pharmaceutical

General Information

Company Name XtalPi Inc.
Founded Year 2014
Location United States Somerville, United States
Employees 398
Industries Biotechnology, Pharmaceutical
Funding Stage IPO
Business Model B2B, Platform, SaaS
Revenue Model Project Based, Performance Based, Usage Based
Offices as of Nov 2026
Somerville, United States Shenzhen, China Beijing, China
Social

BounceWatch is an independent company data service, not affiliated with XtalPi Inc.. To contact XtalPi Inc., visit xtalpi.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does XtalPi Inc. compare?

A PDF of XtalPi Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting XtalPi Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

New Partnership Nov 03, 2026

XtalPi Inc. announced a new partnership with Dubai Medical University to explore regional traditional medicine using AI and robotics.

Event Participation Nov 02, 2026

XtalPi hosted the "AI for Science: From Prediction to Discovery" symposium during SWITCH 2026 in Singapore.

Growth Metrics Oct 27, 2026

XtalPi's automated labs generate around 500,000 reaction data points each month across 23 reaction types.

Award Received Oct 22, 2026

XtalPi was included in the HKEX Artificial Intelligence Index as one of its ten largest constituents.

XtalPi Inc. a competitor of yours? Have our desk watch it

AI Insight

Bounce Watch AI
1 month ago

XtalPi Inc. is demonstrating strong post-IPO momentum, characterized by significant technological advancements with its enhanced retrosynthesis model, a strategic drug discovery partnership with Stanford University, and confirmed global operational expansion into new markets. These recent developments, alongside ongoing hiring and active event participation, underscore the company's aggressive strategy to solidify its leadership in AI-driven pharmaceutical R&D.

Signal Types
Product Launch Partnership Expansion Hiring Event
Strategic Labels
Technology Advancement Strategic Partnerships Global Expansion
Next Move: Market Expansion
·
Impact: 9/10
·
Ideal For: Public Market Investors — AI Biotech

About XtalPi Inc.

XtalPi Inc., founded in 2014, stands at the forefront of the biotechnology and pharmaceutical industries with a focused mission to redefine drug discovery. The company leverages a unique fusion of quantum physics, AI, and robotics to accelerate and enhance drug development, aiming to improve speed, scale, novelty, and success rates.

Operating in both China and the United States, XtalPi's strength lies in its integrated technology platform. This platform effectively combines cloud supercomputing-powered in silico tools with robotic automation in their wet lab, creating a cohesive loop between dry and wet lab processes. Such capabilities position them well in a landscape increasingly driven by AI and automation in pharmaceutical development.

The company's consistent focus on innovation and strategic market presence has attracted substantial investments. Their most recent financing round was a $368.02M Post IPO Debt investment in January 2026. The backing of renowned investors underscores confidence in XtalPi's forward-leaning vision and execution prowess. This solidifies its future in advancing the world of drug R&D.

Business keywords: AI-Powered Drug Discovery, Quantum Physics for R&D, Robotics in Drug Development, Cloud Supercomputing, In Silico Drug Development, Wet Lab Automation, Integrated Technology Platform, Iterative Feedback Loop, Pharmaceutical Innovation, Experimental Data Integration, Computing-Driven Pharmacology, Therapeutics Development, Biotech R&D, AI4Science

Services & Products

AI & Quantum Physics Integration
Automated Experimental Robotics
Pharmaceutical Patent Analysis Tools
Advanced Molecular Synthesis Platforms
Crystalline Structure Analysis
High-Accuracy Energy Calculations

Target Customers

Pharmaceutical Companies Biotech Researchers Chemical Industry Professionals Material Science Innovators AI and Machine Learning Enthusiasts Academic and Research Institutions

Funding Rounds & Investors (11)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt $368.02M -
01 Jan 2026
Post-IPO Equity $268.00M -
01 Apr 2025
IPO CNY337.00M 4
Biocytogen
Biocytogen, Guosheng Group +2
01 Jun 2024
Series D $400.00M 5
OrbiMed 5Y Capital Sino Biopharma
OrbiMed, 5Y Capital +3
01 Aug 2021
Series C $318.80M 8
SoftBank 5Y Capital PICC Capital
SoftBank, 5Y Capital +6
01 Sep 2020
Series B Undisclosed 1
5Y Capital
5Y Capital
01 Aug 2019
Series B $46.00M -
01 Oct 2018
Series B $15.00M 3
Sequoia, Tencent +1
01 Jan 2018
Series A CNY400.00K -
01 Jun 2016
Series A $5.00M 3
ZhenFund
ZhenFund, Tencent +1
01 Nov 2015

View All 11 Funding Rounds

XtalPi Inc. Alternatives & Competitors

View All Alternatives
XtalPi Inc. vs
AsedaSciences®
AsedaSciences® Switzerland

Helping scientists develop safer chemicals

11 employees
Biotechnology, Life Sciences
XtalPi Inc. vs
Insilico Medicine
Insilico Medicine United States

#insilicomeds, #drugdiscovery, #ai, #oncology, #RL, #DL #aging, #longevity #biologics #LLMS #AIDD

IPO
286 employees
AI, Biotechnology
XtalPi Inc. vs
Dalriada Drug Discovery
Dalriada Drug Discovery Canada

Small Molecule Drug Discovery Services

Seed
38 employees
Biotechnology, Pharmaceutical
Also compare with: XtalPi Inc. vs Enable Medicine Enable Medicine View all alternatives

FAQ About XtalPi Inc.

Dedicated to building a technology platform using AI and robotics to drive innovation in multiple industries.
XtalPi Inc. was founded in 2014.
XtalPi Inc. is headquartered in Somerville, United States. As of Nov 2026, it also has offices in Shenzhen, China and Beijing, China.
XtalPi Inc. operates in Biotechnology and Pharmaceutical. Its work centres on AI-Powered Drug Discovery, Quantum Physics for R&D, Robotics in Drug Development and Cloud Supercomputing. Its customers include Pharmaceutical Companies, Biotech Researchers and Chemical Industry Professionals.
XtalPi Inc. has a B2B, Platform and SaaS business model. Its revenue comes from Project Based, Performance Based and Usage Based.
XtalPi Inc. has approximately 398 employees.
XtalPi Inc. has completed 11 funding rounds, raising a total of $1.76B. The latest funding stage is IPO.
XtalPi Inc. offers: AI & Quantum Physics Integration, Automated Experimental Robotics, Pharmaceutical Patent Analysis Tools, Advanced Molecular Synthesis Platforms, Crystalline Structure Analysis, High-Accuracy Energy Calculations.
Top alternatives and competitors to XtalPi Inc. include AsedaSciences®, Insilico Medicine, Dalriada Drug Discovery, iktos, Synbio Technologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
XtalPi Inc. and AsedaSciences® are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for XtalPi Inc., https://bouncewatch.com/company/xtalpi-inc, updated 6 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout